This legislation aims to improve the Medicare payment system for skin substitute products used in wound care, ensuring these essential treatments are adequately covered and reimbursed. By formally including skin substitute products in Medicare coverage, the bill establishes a new payment structure set to take effect on January 1, 2026. Under this structure, Medicare will determine payment amounts based on the volume-weighted average of existing limits for these products, with annual updates tied to the Consumer Price Index.